Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

MacroGenics, Inc.

By efain on Thu, 06/04/2020 - 13:36
  • Read more about MacroGenics, Inc.

First-in-human Single Agent Study of SAR442257 in RRMM and RR-NHL

  • Read more about First-in-human Single Agent Study of SAR442257 in RRMM and RR-NHL

One-year Outcomes in Survivors of the Severe COVID-19 Pneumonia (CO-Qo-ICU)

  • Read more about One-year Outcomes in Survivors of the Severe COVID-19 Pneumonia (CO-Qo-ICU)

COVID-19 Associated Lymphopenia Pathogenesis Study in Blood

  • Read more about COVID-19 Associated Lymphopenia Pathogenesis Study in Blood

Investigating a Vaccine Against COVID-19

  • Read more about Investigating a Vaccine Against COVID-19

Serological and PCR Testing for COVID-19

  • Read more about Serological and PCR Testing for COVID-19

Pulmozyme to Improve COVID-19 ARDS Outcomes

  • Read more about Pulmozyme to Improve COVID-19 ARDS Outcomes

The Açaí Berry COVID-19 Anti-Inflammation Trial

  • Read more about The Açaí Berry COVID-19 Anti-Inflammation Trial

Cardiac Imaging in SARS-CoV-2 (COVID-19)

  • Read more about Cardiac Imaging in SARS-CoV-2 (COVID-19)

COVID-19: Respiratory and Sleep Follow-up

  • Read more about COVID-19: Respiratory and Sleep Follow-up

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 204
  • Page 205
  • Page 206
  • Page 207
  • Current page 208
  • Page 209
  • Page 210
  • Page 211
  • Page 212
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA